[1]
Verma, S.K., Bala, S. and Singh, Y. 2019. Assessment of levetiracetam and valproic acid as monotherapy for quality of life in partial epilepsy patients. International Journal of Basic & Clinical Pharmacology. 8, 11 (Oct. 2019), 2434–2439. DOI:https://doi.org/10.18203/2319-2003.ijbcp20194779.